Research published in nutrition journals confirms that high-protein meals generate sustained GLP-1 elevation for 23 hours after eating, creating prolonged satiety without additional medication
Evidence-based approaches include stress management techniques (mindfulness, CBT), maintaining good sleep hygiene (79 hours nightly), regular moderate-intensity exercise, and a balanced diet
AI is also improving clinicians ability to understand patients metabolic health beyond standard measures like blood glucose and A1C
The medical rationale for weight loss in people with obesity is that obesity is a disease associated with a significant increase in mortality and many health risks, including type 2 diabetes mellitus, hypertension, dyslipidemia, and coronary heart disease
Both incorporate tirzepatide, a dual-action medication targeting GIP and GLP-1 receptors, but their FDA approvals set them apart: Mounjaro is strictly for type 2 diabetes while Zepbound is targeted at weight loss